DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @Tickeron | 13 |
| @newsfilterio | 8 |
| @Gambiste1 | 5 |
| @otcdynamics | 5 |
| @StockTexts | 4 |
Recent Tweets for MYGN
 |
@Tickeron $MYGN's 10-day Moving Average crossed below its 50-day Moving Average on November 11, 2019. View odds for this and… https://t.co/pD2qaBU4it December 7th 2019, 5:12pm |
 |
@1MinuteStock Wondering about risks of $MYGN? The 21-day volatility is 13.75% https://t.co/CJdCMrKQTJ December 6th 2019, 11:12pm |
 |
@Gambiste1 RT @newsfilterio: Grocery Outlet CEO explains why the company has no near-term plans to build an e-commerce operation $MYGN https://t.co/Qt… December 6th 2019, 11:12pm |
|
@Gambiste1 RT @newsfilterio: Donald Kohn: November jobs number reinforces Fed's judgment $MYGN https://t.co/mpRkjN5Hyi https://t.co/v5Fj0rjzN2 December 6th 2019, 11:12pm |
|
@Gambiste1 RT @newsfilterio: McDonald's new chicken sandwich will be a big US hit: Analyst $MYGN https://t.co/dg2m3c9lq0 https://t.co/zQ1YoP4XJZ December 6th 2019, 11:12pm |
 |
@newsfilterio Grocery Outlet CEO explains why the company has no near-term plans to build an e-commerce operation $MYGN… https://t.co/VLkFxmIvTn December 6th 2019, 11:12pm |
|
@newsfilterio Donald Kohn: November jobs number reinforces Fed's judgment $MYGN https://t.co/mpRkjN5Hyi https://t.co/v5Fj0rjzN2 December 6th 2019, 9:12pm |
|
@newsfilterio McDonald's new chicken sandwich will be a big US hit: Analyst $MYGN https://t.co/dg2m3c9lq0 https://t.co/zQ1YoP4XJZ December 6th 2019, 9:12pm |
|
@newsfilterio Full interview with Microchip CEO Steve Sanghi $MYGN https://t.co/NJkjWI9h0P https://t.co/kTuOYESlsk December 6th 2019, 8:12pm |
|
@newsfilterio White House: Won't participate in impeachment hearings $MYGN https://t.co/UOLCIhXcUA https://t.co/NFB1vz26ie December 6th 2019, 8:12pm |
|
@Tickeron $MYGN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/EsG2vjvFkW December 6th 2019, 6:12pm |
|
@newsfilterio Trader lays out how to use options to catch up to tech's big rally $MYGN https://t.co/2veFgVcfrB https://t.co/u5wO62D9a6 December 6th 2019, 6:12pm |
|
@newsfilterio Goldman's Jan Hatzius: The economy is picking up somewhat $MYGN https://t.co/QxOVOt7ew4 https://t.co/9iNtAgEv0v December 6th 2019, 5:12pm |
 |
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/Go12dMNgBI December 6th 2019, 3:12pm |
 |
@InsiderAlertsIA $MYGN: New Insider Filing on Director HEINRICH DREISMANN: https://t.co/idFEKaDEWX December 6th 2019, 2:12pm |
|
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/b6fMhULi4W December 6th 2019, 2:12pm |
|
@1MinuteStock Wondering about risks of $MYGN? The 63-day volatility is 46.83% https://t.co/CJdCMrKQTJ December 6th 2019, 1:12pm |
 |
@AlertTrade RT @SwingTradeBot: Recent $MYGN technical alerts: Narrow Range Bar plus 4 more alerts... https://t.co/1ayvR7H0Cj December 6th 2019, 1:12pm |
|
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/bGeV1tkcZO December 6th 2019, 1:12pm |
 |
@SwingTradeBot Recent $MYGN technical alerts: Narrow Range Bar plus 4 more alerts... https://t.co/1ayvR7H0Cj December 6th 2019, 1:12pm |
|
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 8-K https://t.co/FSGbHDiFQD December 6th 2019, 11:12am |
|
@Tickeron $MYGN's 10-day Moving Average crossed below its 50-day Moving Average on November 11, 2019. View odds for this and… https://t.co/zqYdYVVstB December 5th 2019, 5:12pm |
 |
@BlueBioNow $MYGN is on the move with significant price changes 2.50 % https://t.co/tW3cQXvdPM December 5th 2019, 8:12am |
|
@Tickeron $MYGN's 10-day Moving Average broke below its 50-day Moving Average on November 11, 2019. View odds for this and ot… https://t.co/BVtxG6BANt December 4th 2019, 7:12pm |
 |
@ProVesting $MYGN: Myriad (MYGN) Up 18.4% Since Last Earnings Report: Can It Continue?: https://t.co/ix9LjBdGAE December 4th 2019, 11:12am |
 |
@ProTraderJoe1 Myriad shares fall despite positive results on prenatal test - $MYGN - https://t.co/HtepVCAMRl December 4th 2019, 9:12am |
 |
@otcdynamics $MYGN Myriad’s Prequel™ Prenatal Screen has Superior Sensitivity in Women with High BMI Undergoing Non-Invasive Pre https://t.co/Du5X6O1giK December 4th 2019, 7:12am |
|
@Gambiste1 RT @_B_I_O_T_E_C_H_: $MYGN Myriad’s Prequel™ Prenatal Screen has Superior Sensitivity in Women with High BMI Undergoing Non-Invasive Prenat… December 4th 2019, 7:12am |
 |
@_B_I_O_T_E_C_H_ $MYGN Myriad’s Prequel™ Prenatal Screen has Superior Sensitivity in Women with High BMI Undergoing Non-Invasive Pre… https://t.co/wCUmHzet3E December 4th 2019, 7:12am |
|
@otcdynamics $MYGN Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium https://t.co/Fjf5xQjtVZ December 3rd 2019, 7:12am |
|
@Gambiste1 RT @newsfilterio: Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium $MYGN https:… December 3rd 2019, 7:12am |
|
@newsfilterio Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium $MYGN https://t.co/lv4sKcXBFD December 3rd 2019, 7:12am |
 |
@dailypoliticaln Myriad Genetics, Inc. $MYGN Expected to Announce Earnings of $0.31 Per Share https://t.co/QYke1W6i9h December 2nd 2019, 9:12pm |
 |
@ZolmaxNews Myriad Genetics, Inc. $MYGN Expected to Announce Earnings of $0.31 Per Share https://t.co/egzY0QZkzt December 2nd 2019, 9:12pm |
|
@Tickeron $MYGN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/mlRdklStsg December 2nd 2019, 4:12pm |
|
@Tickeron $MYGN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/dDQoyMYLp0 December 1st 2019, 8:12pm |
 |
@tradersreport RT @Tickeron: $MYGN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/YE9HAgwaM0 #Myriad… November 30th 2019, 10:11pm |
|
@Tickeron $MYGN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/o59K0Jg8RQ November 30th 2019, 10:11pm |
 |
@dispatchtribune Zacks: Analysts Anticipate Myriad Genetics, Inc. $MYGN Will Post Earnings of $0.31 Per Share https://t.co/VJQ9oIEky9 November 30th 2019, 12:11pm |
 |
@WatchlistN $209.24 Million in Sales Expected for Myriad Genetics, Inc. $MYGN This Quarter https://t.co/DRebSVkEIm November 30th 2019, 11:11am |
|
@Tickeron $MYGN's price moved below its 50-day Moving Average on November 5, 2019. View odds for this and other indicators:… https://t.co/2war65vibS November 29th 2019, 4:11pm |
|
@Tickeron $MYGN's price moved below its 50-day Moving Average on November 5, 2019. View odds for this and other indicators:… https://t.co/eHcxVCGzlV November 28th 2019, 3:11pm |
 |
@ThisLincolnian Myriad Genetics, Inc. $MYGN Expected to Announce Earnings of $0.31 Per Share https://t.co/8AoNf5T6de November 28th 2019, 7:11am |
 |
@ConsumerFeed Myriad Genetics, Inc. $MYGN Expected to Announce Earnings of $0.31 Per Share https://t.co/H5ARQVGYZK November 28th 2019, 7:11am |
 |
@dakotafinancial Myriad Genetics $MYGN Stock Price Up 6.4% https://t.co/n5DbQmJ4GZ November 28th 2019, 12:11am |
 |
@TheMarketsDaily Myriad Genetics $MYGN Trading 6.4% Higher https://t.co/mk2oonYdO0 November 28th 2019, 12:11am |
|
@Tickeron $MYGN's price moved below its 50-day Moving Average on November 5, 2019. View odds for this and other indicators:… https://t.co/xZt6Vra0tJ November 27th 2019, 4:11pm |
 |
@AmericanBanking $209.24 Million in Sales Expected for Myriad Genetics, Inc. $MYGN This Quarter https://t.co/Ed2z8ISIAx #stocks November 27th 2019, 2:11am |
|
@dispatchtribune Brokerages Expect Myriad Genetics, Inc. $MYGN Will Announce Quarterly Sales of $209.24 Million https://t.co/wXgl2qfJ8V November 27th 2019, 2:11am |
 |
@EnterpriseLeade $209.24 Million in Sales Expected for Myriad Genetics, Inc. $MYGN This Quarter https://t.co/GNVM1LVp38 November 27th 2019, 2:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.